Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone: 701-328-2366

Slides:

Advertisements

Similar presentations

The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.

Advertisements

The Burden of Obesity in North Carolina

The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.

The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.

The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.

The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.

National Scorecard, 2008: Chartpack This Chartpack presents data for all indicators scored in the National Scorecard on U.S. Health System Performance,

1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.

National Center for Chronic Disease Prevention and Health Promotion Division of Nutrition, Physical Activity, and Obesity Healthy Communities: Healthy.

Hepatitis B Campaign 28 July.  HEPATITIS B is a liver disease caused by the hepatitis B virus (HBV). WHAT IS HEPATITIS B DISEASE?

Asian Health Coalition of Illinois Hepatitis Education & Prevention Program (HEPP) Program Overview Hong Liu, Ph.D. Executive Director.

Building Effective Advocacy for Hepatitis C Hepatitis C Choices in Care.

Perinatal Hepatitis B Prevention

Estimates of People with Hepatitis C in South Carolina Number People with Reactive anti-HCV Antibody United States Census Bureau 2010: Age and Sex Compositions.

Minnesota Department of Health HIV/AIDS Surveillance System HIGHLIGHTS FROM THE MN HIV SURVEILLANCE REPORT 2014.

Acute Viral Hepatitis. Viral Hepatitis Infectious: Hepatitis A Infectious: Hepatitis A Serum : Hepatitis B, D Serum : Hepatitis B, D NANB : Hepatitis.

Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis Branch Centers for Disease Control and Prevention An Overview.

Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.

Hepatitis B workshop on Identifying Aims, Goals, Gaps, and Priorities for a National Strategy Chronic hepatitis B and associated liver diseases, including.

North Dakota Department of Public Instruction Kirsten Baesler, State Superintendent 600 E. Boulevard Avenue, Dept. 201 Bismarck, ND Gail Schauer.

Chronic Hepatitis B Surveillance Kathleen Harriman California Department of Public Health Immunization Branch November 1, 2012.

A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.

Hepatitis B and C: A silent but deadly epidemic Arun J Sanyal M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Richmond, Virginia.

Departmental Perspectives on Viral Hepatitis

Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.

Module 3: HCV prevalence and course of HCV infection.

SANTANA P. ABRAVANEL L., AUBERT JP.PICARD H. GELLY J. FRARIER M. 1 PREVAC A An evaluation of preventive Hepatitis A vaccination in risk groups WONCA EUROPE.

Safer Needle Devices: Protecting Health Care Workers.

Harold S. Margolis, M.D. Division of Viral Hepatitis

Hepatitis B Virus 28.

Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis D (Delta) Virus Division of Viral Hepatitis.

Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.

Prevent Disease – Promote Wellness – Improve Quality of Life UNIVERSAL/STANDARD PRECAUTIONS BLOODBORNE PATHOGENS Michigan Department of Community Health.

Office of Epidemiology and Prevention Services DIVISION OF INFECTIOUS DISEASE EPIDEMIOLOGY The Burden of Hepatitis C in West Virginia November.

Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.

Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.

Grace Van Ness, MPH, CHES, Ann Thomas, MD, MPH & Sharon Vance

Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.

Sexually Transmitted Disease Epidemiology in North Dakota Chlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV Lindsey VanderBusch STD/HIV/TB/Hepatitis.

Influenza Vaccination Campaign 2003 Dr. Michael Koller QI Director for Primary Care.

2007 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

2011 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

Tuberculosis in North Dakota 2011 Craig Steffens, MPH TB/HIV Surveillance Coordinator.

2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.

ADAP and Hepatitis B Coverage  In June 2012, 29 ADAPs covered at least one of the medications for HBV on their formularies.  ADAPs filled 325 hepatitis.

Data Limitations Morbidity based on reported positive lab result –Under-reporting of both acute and chronic infections Morbidity based on CDC case definitions.

Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.

| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.

Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,

County of Los Angeles Department of Health Services IMMUNIZATION PROGRAM Using Non-Traditional Immunization Settings to Immunize.

Federal Welcome: A View from the Office of HIV/AIDS and

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Hepatitis C Virus Program in Chicago

Addressing Viral Hepatitis

is caused by the Hepatitis A virus (HAV)

Collaborations/Coordination

Hepatitis C Incidence and Prevalence in the U.S.

Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,

A qualitative assessment of factors impacting adoption and implementation of USPSTF age-based hepatitis C virus screening recommendations Amy B. Jessop,

Summary Report: Management of Hepatitis C in Prisons

Viral Hepatitis in Correctional Settings

HCV: Who Should We Screen and Why?

Expanding the Universe of Viral Hepatitis Treaters

Hepatitis B in People of African Origin

Number of HCV tests conducted

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Hepatitis C: After the Diagnosis

Progress in Facilitating National HCV Prevention

Hepatitis Training in a STD Clinical Program

Presentation transcript:

Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:

 Provide hepatitis C screening and counseling and hepatitis A and B vaccination to at risk clients at 11 local public health units 

 Chronic viral hepatitis is ◦ a serious public health problem in the U.S. ◦ poorly understood by providers, public, and policy makers  Lack of awareness and knowledge results in ◦ Missed opportunities for prevention  Inadequate investments in viral hepatitis services and care A-National-Strategy-for-Prevention-and-Control-of- Hepatitis-B-and-C.aspx

Cases Reported to ND Department of Health 2009 Morbidity *2005 is baseline year for reported positive lab results for HBV & HCV data not de-duplicated with years prior to 2005.

Reported Hepatitis B Cases by Year North Dakota,

North Dakota Hepatitis B Cases* by Gender; 2009 *Based on reported positive lab result N=69

North Dakota Hepatitis B Cases* by Age Group; 2009 *Based on reported positive lab result N=69

Reported Hepatitis C Cases* by Year North Dakota, * Includes acute and “past or present” infections

North Dakota Hepatitis C Cases* by Gender; 2009 *Based on reported positive lab result N=514

North Dakota Hepatitis C Cases* by Age Group; 2009 *Based on reported positive lab result N=514